Prostate Cancer Calculators
Prostate cancer biomarker test - Diagnolita
Article of the Month: ERSPC and PCPT risk calculators in prostate cancer risk prediction – BJUI
Next-generation prostate cancer risk calculator for primary care physicians. | Semantic Scholar
Version 2.0 of Prostate Cancer Risk Calculator Online
Prostate Cancer (Part 2): Cancer Risk Calculator (MSKCC Pre-Prostatectomy Nomogram) - YouTube
Kaiser Permanente researchers develop new prostate cancer risk calculator – NCAL Research Spotlight
Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
Diagnostics | Free Full-Text | Liquid Biopsy Potential Biomarkers in Prostate Cancer
Screenshots of the Rotterdam Prostate Cancer Risk Calculator app,... | Download Scientific Diagram
A Device for Predicting Prostate Cancer Risk: A Logistic Regression | Semantic Scholar
Cancer Risk on the App Store
The Rotterdam Prostate Cancer Risk Calculator decision tree. PSA:... | Download Scientific Diagram
Health Beat: Prostate cancer: What's your risk? | Health | wfmz.com
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
Risk-Calculator Articles
Know Your Prostate Cancer Risk: Calculator and Risk Factors - Ezra
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus
Personalizing Prostate Cancer Diagnosis with Multivariate Risk Prediction Tools: How Should Prostate MRI Be Incorporated? - Beyond the Abstract
Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
Rotterdam Prostate Cancer Risk – Apps on Google Play
